MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy

BACKGROUND: The study was undertaken to assess the efficacy of methotrexate (MTX) monotherapy on the radiographic progression of individual rheumatoid arthritis (RA) patients, each of whom had received MTX monotherapy for 3 years with an option to change to biological disease-modifying anti-rheumati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiozawa, Kazuko, Yamane, Takashi, Murata, Miki, Yoshihara, Ryosuke, Tsumiyama, Ken, Imura, Shigeaki, Shiozawa, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769545/
https://www.ncbi.nlm.nih.gov/pubmed/26922083
http://dx.doi.org/10.1186/s13075-016-0948-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769545/
https://www.ncbi.nlm.nih.gov/pubmed/26922083
http://dx.doi.org/10.1186/s13075-016-0948-7

Ejemplares similares